Industry Trend

Site Sections


Menu













© 2023. All Rights reserved.

Overview for ROCHE

All Data per May 25, 2023

Industry:

Drug Manufacturers—General

Last Close:

290.70 CHF

Expected Dividend:

3.27 %

Payoffs per Year:

1
Business Summary

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors, as well as with Surface Oncology, Inc. to evaluate SRF388. The company was founded in 1896 and is headquartered in Basel, Switzerland.


Competitors View

Ordering

PFIZER

USA
0.89 3.74%
4.36%
6.07% 4.49% 1.0 0.61
-43.29%
46.05 16.02% 48.64 1.0

ABBVIE

USA
1.02 3.5%
4.3%
10.17% 5.07% 1.0 3.15
-14.88%
42.79 13.02% 12.45 2.0

ASTRAZENECA

GBR
1.06 3.6%
2.11%
5.97% 4.3% 0.5 16.21
-3.86%
67.14 17.71% 38.41 3.0

SANOFI

FRA
1.11 3.8%
3.58%
1.59% 3.73% 1.0 0.88
-12.18%
49.68 12.1% 59.3 4.0

CHUGAI PHARMACEUTICAL

JPN
0.98 1.38%
2.08%
16.13% 2.65% 1.0 3.06
-38.8%
42.96 15.38% 77.21 5.0

MERCK & CO.

USA
1.09 3.4%
2.67%
5.29% 3.94% 1.0 3.67
-11.68%
47.47 8.91% 42.19 6.0

BRISTOL-MYERS SQUIBB

USA
0.95 2.6%
4.47%
2.48% 2.66% 1.0 0.53
-24.44%
34.16 17.14% 32.14 7.0

ASTELLAS PHARMA

JPN
1.01 2.35%
2.85%
19.78% 5.38% 1.0 1.47
-19.06%
31.03 -2.41% 62.61 8.0

ELI LILLY AND COMPANY

USA
1.1 2.36%
1.06%
14.8% 4.25% 1.0 11.83
-12.71%
45.05 7.83% 21.77 9.0

AMGEN

USA
0.95 2.75%
3.93%
10.11% 3.97% 1.0 1.83
-17.4%
38.25 -3.13% 5.62 10.0

DAIICHI SANKYO

JPN
1.07 2.05%
0.7%
6.06% 2.46% 1.0 10.21
-17.26%
41.99 11.62% 60.81 11.0

KYOWA HAKKO KOGYO

JPN
0.95 1.65%
1.91%
8.0% 2.16% 1.0 3.07
-15.61%
44.19 3.67% 81.16 12.0

OTSUKA HOLDINGS CO., LTD.

JPN
1.01 2.16%
1.93%
0.0% 1.98% 1.0 0.44
-14.62%
29.23 12.66% 72.92 13.0

ROCHE

CHE
0.92 3.1%
3.27%
1.69% 3.06% 1.0 0.55
-23.37%
40.4 0.0% 36.32 14.0

GILEAD SCIENCES

USA
1.04 3.5%
3.89%
3.61% 3.76% 0.5 0.24
-42.43%
36.76 3.95% 33.57 15.0

JOHNSON & JOHNSON

USA
0.96 2.69%
3.05%
5.9% 3.2% 1.0 0.19
-12.62%
46.37 -0.95% 40.99 16.0

BAYER

GER
1.06 2.96%
3.68%
0.81% 2.81% 0.5 -0.3
-58.76%
37.48 -6.72% 31.17 17.0

GLAXOSMITHKLINE

GBR
1.02 6.49%
2.62%
0.0% 5.95% -1.0 0.02
-24.56%
47.0 -2.84% 16.79 18.0

GRIFOLS SA

ESP
0.91 1.1%
0.0%
-53.18% 0.2% -0.5 -0.11
-65.73%
32.66 2.01% 38.04 19.0


Information for ROCHE

Yield Triangle

Dividend & Close

Dividend Close Div.-Yield
Year
2023 9.50 290.70 3.27
2022 9.30 290.50 3.20
2021 9.10 379.10 2.40
2019 8.70 314.00 2.77
2018 8.30 243.40 3.41
2017 8.20 246.50 3.33
2016 8.10 232.60 3.48
2015 8.00 276.40 2.89
2014 7.80 269.90 2.89
2013 7.35 249.20 2.95

Fundamentals

Chart